Medical societies such as the European Society of Medical Oncology (ESMO) in Europe or the National Comprehensive Cancer Network (NCCN) create guidelines which outline the standards of care for different types of cancer – among them guidelines for soft tissue sarcoma, bone sarcoma and GIST.
These guidelines provide recommendations about diagnosis, treatment and follow-up for healthcare professionals to follow when treating a particular type of cancer. If you are interested to know what the standards of care for soft tissue sarcoma, bone sarcoma and GIST currently, please find links to the current guidelines below. Please note that these guidelines are not written in a patient friendly form.
- Soft Tissue and Visceral Sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, updated in 2021
- Bone Sarcomas: ESMO–PaedCan–EURACAN: Clinical Practice Guidelines for diagnosis, treatment and follow-up, updated in 2021
- Gastrointestinal Stromal Tumours: Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, updated in 2021
- NCCN Clinical Practice Guidelines in Oncology
- NCCN Guideline for Patients about Soft Tissue Sarcomas in Adults, published in 2018
- The Management of Desmoid Tumors: A joint global evidence-based consensus guidelineapproach for adult and pediatric patients
by the Desmoid Working Group, updated and published 2018/2019
There might be additional guidelines available on a national level as well.